KayoThera

Series-A
kayothera.com Biotech & Healthcare
Total Funding $8M
Latest Round Undisclosed Series-A
Last Announced Jul 19, 2023
Investors Undisclosed
Decision Makers 1 Available

About KayoThera

A nuclear target to revive anti-tumor immunity.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website kayothera.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $8,000,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for KayoThera.

Funding History

2 Rounds
Series-A equity · Jul 19, 2023
Series-A equity · Mar 16, 2022

Founders & Leadership

2

MARK ESPOSITO

CSO Co-Founder and Board Member

Work email & phone locked Unlock →

YIBIN KANG

Chair, Scientific Advisory Board and Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts